Polygenic Risk of Disease in Populations of Diverse Ancestry
不同血统人群的多基因疾病风险
基本信息
- 批准号:10670372
- 负责人:
- 金额:$ 60.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-08 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdmixtureAdultAll of Us Research ProgramCategoriesClassificationClinicalCollaborationsComplexComputing MethodologiesCoronary heart diseaseDataData ElementData SetDevelopmentDiabetes MellitusDiseaseEast AsianElectronic Health RecordElectronic Medical Records and Genomics NetworkEnsureEquationEquityEuropean ancestryGene FrequencyGenerationsGeneticGenetic DiseasesGenetic VariationGenomic medicineGenotypeGoalsGrantHealthHeritabilityHypertensionIndividualInternationalLinkage DisequilibriumMetadataMethodsMiddle EasternModelingObesityOntologyOutcomePatternPerformancePhasePhenotypePopulationPopulation GeneticsPopulation HeterogeneityPreventionPublic HealthRiskRisk EstimateRisk FactorsSample SizeSiteSourceSouth AsianStatistical MethodsTestingTherapeuticVariantVeteransWeightWorkbiobankclinic readyclinical decision-makingclinical practiceclinical riskcloud platformcohortdata harmonizationdata integrationdata modelingdata standardsdatabase of Genotypes and Phenotypesdisorder riskgenome wide association studygenomic datahealth disparityheart disease riskhypercholesterolemiaimprovedinnovationlarge datasetsnovelphenotypic datapolygenic risk scoreprecision medicineprogramsrandomized, clinical trialsrisk predictionrisk stratificationrisk variantstatisticsworking group
项目摘要
PROJECT SUMMARY
In this application we propose to build on our prior work on polygenic risk scores (PRSs) to extend these to
diverse ancestry groups. By improving risk stratification, PRSs for common diseases have the potential to
transform clinical practice. However, such PRSs must be available for diverse ancestry groups to ensure
equitable implementation of genomic medicine and reduce the potential exacerbation of health disparities in
the context of genomic medicine. Our application aims to address the critical need to develop PRSs for diverse
ancestry groups and will focus on coronary heart disease (CHD) and its risk factors: hypertension, diabetes,
obesity and hypercholesterolemia, collectively an enormous health burden world-wide. CHD is the prototypical
complex disease for the use of PRSs given available validated risk prediction equations that bin individuals into
risk categories and substantial reclassification across these categories by a PRS with consequent therapeutic
implications. As part of the PRS Diversity Consortium (PRS-DC), we will develop methods to generate PRSs
for populations of diverse ancestry using existing and new datasets with genomic and phenotype data for CHD
and its risk factors. We will harmonize data elements across these data sets. The methods we develop will be
applicable towards the generation of PRSs for a broad range of common diseases across diverse populations.
The investigative team is part of the Mayo eMERGE IV application and will serve as a bridge between the
PRS-DC and eMERGE. To generate PRSs for diverse ancestries, we will use data from the eMERGE
consortium, Million Veteran’s Program (MVP), the All of US (AoU) program, dbGAP, PRS-DC sites, UK
Biobank, and collaborations with several international groups representing the Middle Eastern, South Asian
and East Asian cohorts. Our application includes several innovations to enable the use of PRSs for risk
stratification and prevention of CHD in individuals belonging to diverse ancestries. Our specific aims are:
Specific aim 1. Integrate and harmonize phenotype data from heterogeneous sources to enable cross platform
phenotyping and generation of PRSs for common diseases in diverse ancestry groups. Specific aim 2. Develop
PRSs for CHD and its major risk factors (hypertension, diabetes, obesity, hypercholesterolemia) in populations
of diverse ancestry. Specific aim 3. Develop novel statistical and computational methods to account for
diverse genetic ancestry and admixture in models of polygenic risk. Specific aim 4. Develop ‘clinic ready’ PRSs
for diverse ancestry groups by creating reference distributions of a PRSCHD and integrate it with clinical
information to compute absolute risk estimates.
项目摘要
在此应用程序中,我们建议以我们先前在多基因风险分数(PRS)为基础的工作中扩展到这些工作
潜水血统群体。通过改善风险分层,普通疾病的PRS有可能
改变临床实践。但是,这样的PRS必须适合潜水祖先以确保
公平的基因组医学实施,并减少健康分布的潜在加剧
基因组医学的背景。我们的申请旨在满足为潜水员开发PRS的关键需求
祖先,将关注冠心病(CHD)及其危险因素:高血压,糖尿病,
肥胖和高胆固醇血症,全球范围内总体健康。冠心病是原型的
使用PRS的复杂疾病给定可用的经过验证的风险预测方程
随之而来的治疗
含义。作为PRS多样性财团(PRS-DC)的一部分,我们将开发生成PRS的方法
对于使用现有和新数据集的多样性血统群体,具有基因组和表型数据的冠心病
及其风险因素。我们将在这些数据集中协调数据元素。我们开发的方法将是
适用于在潜水员种群中广泛的普通疾病的生成PRS。
调查团队是Mayo Emerge IV应用的一部分,将作为
PRS-DC和出现。为了为潜水员生成PRS,我们将使用来自Emerge的数据
财团,百万退伍军人计划(MVP),我们所有人(AOU)计划,DBGAP,PRS-DC网站,英国,英国
生物库,以及与代表中东,南亚的几个国际团体合作
和东亚人群。我们的申请包括几项创新,以实现PRS的风险
属于潜水祖先的个体的分层和预防冠心病。我们的具体目的是:
特定目的1。从异质来源整合和协调表型数据以启用跨平台
在潜水祖先的常见疾病群体中的表型和生成PRS。具体目标2。
冠心病及其主要危险因素(高血压,糖尿病,肥胖,高胆固醇血症)的PRSS
潜水血统。特定目的3。开发新颖的统计和计算方法来说明
潜水员的遗传血统和多基因风险模型中的混合物。特定目标4。开发“诊所就绪” PRS
通过创建PRSCHD的参考分布并将其与临床整合在一起,以实现多样性祖先组
信息以计算绝对风险估计。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Use of Polygenic Risk Scores for Coronary Heart Disease in Ancestrally Diverse Populations.
- DOI:10.1007/s11886-022-01734-0
- 发表时间:2022-09
- 期刊:
- 影响因子:3.7
- 作者:Dikilitas, Ozan;Schaid, Daniel J.;Tcheandjieu, Catherine;Clarke, Shoa L.;Assimes, Themistocles L.;Kullo, Iftikhar J.
- 通讯作者:Kullo, Iftikhar J.
Implementing Reporting Standards for Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease.
- DOI:10.1007/s11883-023-01104-3
- 发表时间:2023-06
- 期刊:
- 影响因子:5.8
- 作者:Smith, Johanna L.;Schaid, Daniel J.;Kullo, Iftikhar J.
- 通讯作者:Kullo, Iftikhar J.
Polygenic scores in biomedical research.
- DOI:10.1038/s41576-022-00470-z
- 发表时间:2022-09
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Polygenic risk score for peripheral artery disease: A tool to refine risk stratification.
- DOI:10.1177/1358863x221080191
- 发表时间:2022-06
- 期刊:
- 影响因子:3.5
- 作者:Kullo, Iftikhar J.
- 通讯作者:Kullo, Iftikhar J.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Iftikhar J Kullo其他文献
Iftikhar J Kullo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Iftikhar J Kullo', 18)}}的其他基金
Polygenic Risk of Disease in Populations of Diverse Ancestry
不同血统人群的多基因疾病风险
- 批准号:
10210804 - 财政年份:2021
- 资助金额:
$ 60.41万 - 项目类别:
EHR-Based Strategies to Improve Outcomes in Familial Hypercholesterolemia
基于 EHR 的改善家族性高胆固醇血症预后的策略
- 批准号:
9389934 - 财政年份:2017
- 资助金额:
$ 60.41万 - 项目类别:
Patient-Oriented Research in Genomic Discovery and Implementation
以患者为中心的基因组发现和实施研究
- 批准号:
10221769 - 财政年份:2017
- 资助金额:
$ 60.41万 - 项目类别:
Plasma Osteoprotegerin and Adverse Outcomes in CHD Patients
血浆骨保护素和冠心病患者的不良后果
- 批准号:
8467044 - 财政年份:2012
- 资助金额:
$ 60.41万 - 项目类别:
Plasma Osteoprotegerin and Adverse Outcomes in CHD Patients
血浆骨保护素和冠心病患者的不良后果
- 批准号:
8262563 - 财政年份:2012
- 资助金额:
$ 60.41万 - 项目类别:
EHR-based Genomic Discovery and Implementation
基于 EHR 的基因组发现和实施
- 批准号:
10469667 - 财政年份:2011
- 资助金额:
$ 60.41万 - 项目类别:
Genomic Basis of Susceptibility to COVID-19 Infection and its Complications
COVID-19 感染及其并发症易感性的基因组基础
- 批准号:
10165210 - 财政年份:2011
- 资助金额:
$ 60.41万 - 项目类别:
EHR-based Genomic Discovery and Implementation
基于 EHR 的基因组发现和实施
- 批准号:
10207706 - 财政年份:2011
- 资助金额:
$ 60.41万 - 项目类别:
EHR-based Genomic Discovery and Implementation (Pediatric Participants Supplement)
基于 EHR 的基因组发现和实施(儿科参与者补充材料)
- 批准号:
10849461 - 财政年份:2011
- 资助金额:
$ 60.41万 - 项目类别:
EHR-based Genomic Discovery and Implementation
基于 EHR 的基因组发现和实施
- 批准号:
10674944 - 财政年份:2011
- 资助金额:
$ 60.41万 - 项目类别:
相似国自然基金
烯丙基叠氮动态平衡混合物的动态动力学拆分
- 批准号:22371245
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
诱导契合金属有机框架分离C3轻烃混合物
- 批准号:22301102
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
非均匀混合物等效辐射不透明度模型的理论研究
- 批准号:12374259
- 批准年份:2023
- 资助金额:52.00 万元
- 项目类别:面上项目
高黏度不挥发组分在混合物气泡生长及脱离过程中的扩散行为及非平衡效应
- 批准号:52376001
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
氢气及其混合物与涡流管耦合特性底层机制及氢能系统性能优化策略研究
- 批准号:52376212
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
相似海外基金
Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations
SARS-CoV-2 感染和遗传变异的相互作用对祖先和混血人群认知能力下降和阿尔茨海默病风险的影响
- 批准号:
10628505 - 财政年份:2023
- 资助金额:
$ 60.41万 - 项目类别:
Methods for leveraging family-based designs and summary data to elucidate complex trait genetics
利用基于家族的设计和汇总数据来阐明复杂性状遗传学的方法
- 批准号:
10713748 - 财政年份:2023
- 资助金额:
$ 60.41万 - 项目类别:
The Study of Muscle and Physical Performance in African Caribbeans.
非洲加勒比海地区肌肉和身体表现的研究。
- 批准号:
10598636 - 财政年份:2022
- 资助金额:
$ 60.41万 - 项目类别: